{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T13:01:55Z","timestamp":1780146115868,"version":"3.54.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s11605-019-04389-5","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T17:02:30Z","timestamp":1582563750000},"page":"1071-1076","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Disparities in Treatment for Gallbladder Carcinoma: Does Treatment Site Matter?"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2797-8223","authenticated-orcid":false,"given":"A.","family":"Melillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Spitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.","family":"Atabek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Gaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young K.","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1007\/s11605-019-04389-5_bb0010","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jso.23762","article-title":"Outcomes in biliary malignancy","volume":"110","author":"Groot Koerkamp","year":"2014","journal-title":"J Surg Oncol"},{"key":"10.1007\/s11605-019-04389-5_bb0015","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.suronc.2012.08.002","article-title":"Gallbladder cancer: past, present and an uncertain future","volume":"21","author":"Boutros","year":"2012","journal-title":"Surg Oncol"},{"key":"10.1007\/s11605-019-04389-5_bb0020","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s11605-007-0181-4","article-title":"A curative resection improves the postoperative survival rate even in patients with advanced gallbladder carcinoma","volume":"11","author":"Kai","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1007\/s11605-019-04389-5_bb0025","unstructured":"Network, N.C.C. Gallbladder Cancer (Version 2.2019). February 3, 2019]; Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/hepatobiliary.pdf."},{"key":"10.1007\/s11605-019-04389-5_bb0030","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1007\/s11605-015-2922-0","article-title":"Adjuvant Therapy for Gallbladder Cancer: an Analysis of the National Cancer Data Base","volume":"19","author":"Hoehn","year":"2015","journal-title":"J Gastrointest Surg"},{"key":"10.1007\/s11605-019-04389-5_bb0035","doi-asserted-by":"crossref","unstructured":"Mantripragada KC, Hamid F, Shafqat H, Olszewski AJ. Adjuvant Therapy for Resected Gallbladder Cancer: Analysis of the National Cancer Data Base. J Natl Cancer Inst 2017; 109:2.","DOI":"10.1093\/jnci\/djw202"},{"key":"10.1007\/s11605-019-04389-5_bb0040","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1007\/s11605-010-1335-3","article-title":"National trends in the management and survival of surgically managed gallbladder adenocarcinoma over 15 years: a population-based analysis","volume":"14","author":"Mayo","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"10.1007\/s11605-019-04389-5_bb0045","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/00000658-200010000-00011","article-title":"Gallbladder cancer: comparison of patients presenting initially for definitive operation with those presenting after prior noncurative intervention","volume":"232","author":"Fong","year":"2000","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-019-04389-5_bb0050","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1001\/jama.2017.5702","article-title":"Association Between Teaching Status and Mortality in US Hospitals","volume":"317","author":"Burke","year":"2017","journal-title":"Jama"},{"key":"10.1007\/s11605-019-04389-5_bb0055","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.surg.2015.01.027","article-title":"The impact of resident involvement on surgical outcomes among patients undergoing hepatic and pancreatic resections","volume":"158","author":"Ejaz","year":"2015","journal-title":"Surgery"},{"key":"10.1007\/s11605-019-04389-5_bb0060","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/bjs.9492","article-title":"Failure to rescue as a source of variation in hospital mortality after hepatic surgery","volume":"101","author":"Spolverato","year":"2014","journal-title":"Br J Surg"},{"key":"10.1007\/s11605-019-04389-5_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijsu.2018.02.052","article-title":"Adjuvant systemic therapy after resection of node positive gallbladder cancer: Time for a well-designed trial? (Results of a US-national retrospective cohort study)","volume":"52","author":"Bergquist","year":"2018","journal-title":"Int J Surg"},{"key":"10.1007\/s11605-019-04389-5_bb0070","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(18)30915-X","article-title":"Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study","volume":"20","author":"Primrose","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1007\/s11605-019-04389-5_bb0075","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1200\/JCO.18.02178","article-title":"Adjuvant Therapy for Resected Biliary Tract Cancer: ASCO Clinical Practice Guideline","volume":"37","author":"Shroff","year":"2019","journal-title":"J Clin Oncol"}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-019-04389-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11605-019-04389-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23015500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23015500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-019-04389-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:00:23Z","timestamp":1761076823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23015500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":14,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1091255X23015500"],"URL":"https:\/\/doi.org\/10.1007\/s11605-019-04389-5","relation":{},"ISSN":["1091-255X"],"issn-type":[{"value":"1091-255X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disparities in Treatment for Gallbladder Carcinoma: Does Treatment Site Matter?","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-019-04389-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}